LEU stock forecast, quote, news & analysis

Key Takeaways

• Centrus Energy shares fell roughly 14.7% over the past 30 days, sliding from an adjusted close of about $175.70 to $149.85 as of September 17, 2026.
• The decline was driven primarily by a $500 million dilutive equity-and-warrants offering announced in early September, which triggered a sharp single-session selloff.
• Over the last quarter, the stock has retreated approximately 22%, extending a longer stretch of volatility that has also seen meaningful contract wins.
• Fundamentals remain underpinned by a $4.5 billion backlog and multiple high-assay low-enriched uranium (HALEU) supply agreements, though dilution concerns have weighed on sentiment.

Centrus Energy (LEU) Company Overview and Market Position

Centrus Energy Corp. is a Bethesda, Maryland-based supplier of nuclear fuel and related services. The company operates through two segments: Low-Enriched Uranium (LEU), which sells separative work units, uranium, and enriched fuel to utilities, and Technical Solutions, which provides engineering, manufacturing, and operational services to government and private customers.

Centrus holds a distinctive position in the U.S. nuclear supply chain as the only American company licensed to produce high-assay low-enriched uranium (HALEU), the fuel required by many next-generation advanced and small modular reactors. Investors follow LEU closely because of its role in restoring domestic enrichment capacity, its large contractual backlog, and its exposure to rising demand for carbon-free power generation.

Centrus Energy (LEU) Stock Price Performance: Last 30 Days vs. Quarter

Over the past 30 days, LEU has declined approximately 14.7%, moving from an adjusted close of about $175.70 to $149.85. The move was not linear: the stock traded near $185 in early September before the company announced a $500 million public offering, which accelerated a slide to a recent intraday low of $135.85 before a partial rebound.

The quarterly picture is weaker. Over the trailing three months, LEU has fallen roughly 22% from a level near $191 in mid-June. This extends a longer downturn from the stock's 52-week high of $464.25, with shares now trading well below their 200-day moving average.

What Drove LEU Stock Price in the Last 30 Days

The dominant catalyst for the recent decline was financing-related dilution. On September 9, 2026, Centrus announced an underwritten public offering of Class A common stock and warrants, subsequently priced at a combined price of roughly $199.64 per share-equivalent. The transaction included pre-funded warrants and several series of common warrants. Equity offerings typically pressure a stock because new share issuance dilutes existing holders, and LEU fell about 8.6% in a single session following the pricing news.

This financing move overshadowed otherwise positive commercial developments during the period. Centrus signed a long-term HALEU supply agreement with Radiant to support its Kaleidos microreactor fleet and later announced a definitive multi-year HALEU contract with Antares Nuclear. Both agreements include customer prepayments intended to help fund Centrus's domestic enrichment buildout. The Antares announcement helped spark a rebound that lifted shares about 7% in one session, but the stock remains below its pre-offering levels.

Broader sentiment around uranium and advanced-nuclear equities also contributed to the choppiness, as high-beta names in the sector experienced outsized swings during the period.

What Drove LEU Stock Performance Over the Last Quarter

The quarterly decline reflects a mix of strong operational progress and investor concerns about valuation, dilution, and execution risk. On the positive side, Centrus signed a $900 million task order with the U.S. Department of Energy in early July to support commercial-scale enrichment capacity, and in July the company was invited to join the S&P SmallCap 600 index.

Second-quarter 2026 results, reported on August 5, showed revenue of $176.1 million, up 14% year over year, with GAAP net income of $16.8 million and adjusted diluted earnings per share of $1.77. Total backlog reached $4.5 billion extending through 2040. The company also announced HALEU supply agreements with X-energy and a letter of intent with Oklo (OKLO), reinforcing its first-mover role in the advanced-fuel market.

Despite these milestones, the stock trended lower through the quarter as heavy capital-expenditure plans, negative free cash flow, and repeated equity raises weighed on investor confidence, offsetting the constructive demand narrative.

Trending AI Robots

For traders seeking a more systematic approach to volatile names like LEU, Tickeron's Trending AI Robots page offers a curated view of its AI-powered trading bots. Tickeron operates hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section. These bots vary widely in strategy, holding timeframe, and performance metrics, allowing users to evaluate different automated approaches side by side. The page is designed to help investors discover currently active strategies rather than static signals, offering a neutral starting point for those interested in data-driven trading tools.

LEU Stock Forecast Drivers: What Investors Should Watch Next

Investors should monitor Centrus's third-quarter 2026 earnings, expected in early November, along with any updates to full-year revenue guidance of $450 million to $500 million and capital-deployment plans of $350 million to $500 million. Progress on the Piketon, Ohio, enrichment expansion and the Oak Ridge, Tennessee, manufacturing facility—including the company's target of completing its first centrifuge in 2026—will be key operational signposts.

Additional factors include the finalization of the DOE $900 million task order funding, the pace of new HALEU offtake agreements and associated customer prepayments, and any changes to federal support for the HALEU cascade. Macroeconomic conditions, uranium pricing, the pending U.S. ban on Russian uranium imports, and sentiment across advanced-nuclear and AI-driven power-demand equities are also likely to influence the stock. These are informational considerations, not recommendations.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations